Abstract
Statement of Retraction: Dihydroartemisinin targets fibroblast growth factor receptor 1 (FGFR1) to inhibit interleukin 17A (IL-17A)-induced hyperproliferation and inflammation of keratinocytes
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have